Geisinger Health System, a 767-bed health system serving three million patients in PA and NJ, is rooted in innovation and constantly searching for new and better ways to care for patients.
One way Geisinger has led the pack is with their holistic approach to reducing opioid abuse by implementing electronic prescribing for controlled substances (EPCS).
Geisinger’s commitment and choice – to “do good” – also allowed them to “do well” — saving them almost $1M a month. By implementing Imprivata Confirm ID for EPCSTM in conjunction with other safety and security measures, Geisinger is realizing huge returns on their investment.
Read our whitepaper to learn how Imprivata Confirm ID for EPCS has enabled Geisinger to improve provider and patient satisfaction, increase patient safety, and reduce opioid prescribing, all while generating significant cost savings and ROI.
Geisinger’s commitment and choice – to “do good” – also allowed them to “do well” — saving them almost $1M a month. By implementing Imprivata Confirm ID for EPCSTM in conjunction with other safety and security measures, Geisinger is realizing huge returns on their investment.
Read our whitepaper to learn how Imprivata Confirm ID for EPCS has enabled Geisinger to improve provider and patient satisfaction, increase patient safety, and reduce opioid prescribing, all while generating significant cost savings and ROI.
